Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

In 2024 private equity investments and strategic acquisitions drove key deals, particularly in semiconductors and life ...

According to research by UTA's Philip Baiden, Americans aged 65 and older who experienced their parents divorcing as children ...

The new center at Bridge Labs will train the workforce powering North Texas’ biotech boom—helping startups speed therapies, ...

Q4 2024 Management View CEO Arkadiy Dobkin highlighted better-than-expected Q4 results, emphasizing the company's return to organic revenue growth for the first time since Q1 2023. He attributed the ...

Incyte and Genesis Therapeutics have agreed to discover and optimize at least two initial small molecule compounds through Genesis’s AI platform, Genesis Exploration of Molecular Space (GEMS).

Q4 2024 Earnings Call Transcript February 19, 2025 Clarivate Plc beats earnings expectations. Reported EPS is $0.21, ...

Drug development is an expensive and high-risk process. The median cost per approved drug can reach up to $2.8 billion, ...

AI chipmaker Nvidia and research partners have created what they call the largest artificial intelligence system yet for biological research, the company said on Wednesday, aiming to speed up ...

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

Built on Google’s Gemini AI assistant, the tool promises to make research faster and more efficient. But the company ...

A team of US scientists has developed a new foundation model that can sift through genetic code across biology's five ...